Latest filing published 16 Nov 2010 for OPTIMER PHARMACEUTICALS INC, €7,348.
Insider track record
No signal scores available.
Francois-Xavier Frapaise: trading record in brief
Francois-Xavier Frapaise discloses dealings in Optimer Pharmaceuticals Inc to SEC (Form 4). The record holds 3 filings, for trades running from 16 November 2009 to 15 November 2010.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 16 November 2010 came the latest disclosure, a transaction for €7,348 in Optimer Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Francois-Xavier Frapaise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,305 shares@ US$7.71Common stockSEC:0001142576-10-000040:0
- 1,494 shares@ US$9.57Common stockSEC:0001142576-10-000025:0
- 1,412 shares@ US$9.91Common StockSEC:0001142576-09-000027:0
3 of 3 declarations
